The objective of this study will be to assess the coagulation system in-vitro in a variety of bleeding and clotting disorders using the ROTEG analyzer and the thrombin generation assay.
This is an exploratory study involving blood coagulation assays in a select group of individuals receiving treatment for their congenital or acquired bleeding or clotting disorder at UTHealth Houston. The ROTEG is a newly developed coagulation analyzer which allows the continuous assessment of whole blood coagulation from the formation of the first fibrin fibers and activated platelets, to the formation of a three-dimensional whole blood clot until the eventual dissolution of the clot. This device will not be used as a diagnostic or procedure tool. No recommendations regarding interpretation of the results or implications for future treatment will be provided.
Study Type
OBSERVATIONAL
Enrollment
1,000
The Univerisity of Texas Health Science Center at Houston
Houston, Texas, United States
RECRUITINGUT Physicians Women's Center-Texas Medical Center
Houston, Texas, United States
RECRUITINGAssess primary and secondary hemostasis in individuals with bleeding and clotting disorders
Coagulation will be assessed by continuously recording clot firmness, thrombin generation, and platelet function
Time frame: 24 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.